Important Information

You are visiting the international Vantage Markets website, distinct from the website operated by Vantage Global Prime LLP
( www.vantagemarkets.co.uk ) which is regulated by the Financial Conduct Authority ("FCA").

This website is managed by Vantage Markets' international entities, and it's important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:

  • You will not be guaranteed Negative Balance Protection
  • You will not be protected by FCA’s leverage restrictions
  • You will not have the right to settle disputes via the Financial Ombudsman Service (FOS)
  • You will not be protected by Financial Services Compensation Scheme (FSCS)
  • Any monies deposited will not be afforded the protection required under the FCA Client Assets Sourcebook. The level of protection for your funds will be determined by the regulations of the relevant local regulator.

If you would like to proceed and visit this website, you acknowledge and confirm the following:

  • 1.The website is owned by Vantage Markets' international entities and not by Vantage Global Prime LLP, which is regulated by the FCA.
  • 2.Vantage Global Limited, or any of the Vantage Markets international entities, are neither based in the UK nor licensed by the FCA.
  • 3.You are accessing the website at your own initiative and have not been solicited by Vantage Global Limited in any way.
  • 4.Investing through this website does not grant you the protections provided by the FCA.
  • 5.Should you choose to invest through this website or with any of the international Vantage Markets entities, you will be subject to the rules and regulations of the relevant international regulatory authorities, not the FCA.

Vantage wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.

By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Vantage entity.

I confirm my intention to proceed and enter this website Please direct me to the website operated by Vantage Global Prime LLP, regulated by the FCA in the United Kingdom

By providing your email and proceeding to create an account on this website, you acknowledge that you will be opening an account with Vantage Global Limited, regulated by the Vanuatu Financial Services Commission (VFSC), and not the UK Financial Conduct Authority (FCA).

    Please tick all to proceed

  • Please tick the checkbox to proceed
  • Please tick the checkbox to proceed
Proceed Please direct me to website operated by Vantage Global Prime LLP, regulated by the FCA in the United Kingdom.

×

Copy Trade from just $50

Copy Trade Now >
Copy Trade from just $50
View More
SEARCH
  • All
    Trading
    Platforms
    Academy
    Analysis
    Promotions
    About
  • Search
Keywords
  • Forex Trading
  • Vantage Rewards
  • Trading Fees
  • facebook
  • instagram
  • twitter
  • linkedin
  • youtube
  • tiktok
  • spotify
Dividend Announcement 12 Feb 2021

Cash dividend payment schedule for week commencing 15/02/2021

NOTIFICATIONS

RegionMT4/ MT5
Symbols
IssueNameEx-dateAmount per ShareCurrencyTax RateEvent ID
AUSUNSuncorp Group Limited2021.02.150.26AUD02159281
UKTESCOTesco plc2021.02.150.5093GBP02146872
AUCBACommonwealth Bank of Australia2021.02.161.5AUD01994008
AUIAGInsurance Australia Group Limited2021.02.160.07AUD01987280
AUCPUComputershare Limited2021.02.160.23AUD02159466
USCVXChevron Corp.2021.02.161.29USD302148628
USMSFTMicrosoft Corporation2021.02.170.56USD302080289
USSBUXStarbucks Corp.2021.02.170.45USD302138659
AUNCMNewcrest Mining2021.02.180.15USD02161642
UKRDSBRoyal Dutch Shell Plc2021.02.180.1665USD02053283
UKIMBImperial Brands Plc2021.02.180.4801GBP02071427
UKGSKGlaxosmithkline plc2021.02.180.23GBP01789340

IN CASE YOU MISSED IT